Agios Pharm Earnings

The next earnings date for Agios Pharm is October 30, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Agios Pharm Earnings

Report Date	Estimated Earnings Per Share
10/30/2025	$-1.92

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Agios Pharm Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
07/30/2025	Before Market	---	---
04/30/2025	Before Market	$-1.55	11.93%
02/13/2025	Before Market	$-1.74	-6.75%
10/31/2024	Before Market	$-2.42	-318.02%
08/01/2024	Before Market	$-1.69	-5.63%
05/02/2024	Before Market	$-1.45	12.12%
02/15/2024	Before Market	$-1.72	-4.24%
11/02/2023	Before Market	$-1.64	3.53%
08/03/2023	Before Market	$-1.51	3.21%
05/04/2023	Before Market	$-1.47	13.53%
02/23/2023	Before Market	$0.67	141.36%
11/03/2022	Before Market	$-1.49	15.34%
08/04/2022	Before Market	$-1.68	4.00%
05/05/2022	Before Market	$-1.74	3.87%
02/24/2022	Before Market	$-1.74	-2.96%
11/03/2021	Before Market	$-1.56	1.89%
07/29/2021	Before Market	$-1.44	-3.60%
04/29/2021	Before Market	$26.95	2,141.67%
02/25/2021	Before Market	$-1.41	-6.02%
11/05/2020	Before Market	$-1.43	-3.62%
07/30/2020	Before Market	$-1.31	4.38%
04/30/2020	Before Market	$-0.59	64.67%
02/13/2020	Before Market	$-1.60	6.98%
10/31/2019	Before Market	$-1.81	-0.56%
08/01/2019	Before Market	$-1.87	-10.00%
05/02/2019	Before Market	$-1.59	9.14%
02/14/2019	Before Market	$-1.58	5.39%
11/01/2018	Before Market	$-1.63	-0.62%
08/02/2018	Before Market	$-1.19	23.23%
05/04/2018	Before Market	$-1.63	0.00%
02/14/2018	Before Market	$-1.81	-9.04%
11/01/2017	Before Market	$-1.59	11.17%
08/08/2017	Before Market	$-1.78	-14.10%
05/04/2017	Before Market	$-1.56	8.77%
02/16/2017	Before Market	$-1.34	11.26%
11/03/2016	Before Market	$-1.63	-7.24%
08/04/2016	Before Market	$-1.47	-206.25%
05/05/2016	Before Market	$-0.61	22.78%
02/18/2016	Before Market	$-1.08	-116.00%
11/05/2015	Before Market	$-1.07	-21.59%
08/06/2015	Before Market	$-0.85	-84.78%
05/07/2015	Before Market	$-0.13	85.87%
02/17/2015	Before Market	$-0.76	-31.03%
11/07/2014	Before Market	$0.10	119.23%
08/07/2014	---	$-0.54	-35.00%
05/08/2014	---	$-0.39	-5.41%
03/06/2014	---	$-0.40	-17.65%
11/07/2013	---	$-0.47	-62.07%
09/05/2013	---	$-2.80	-775.00%

More About Agios Pharm

Website

https://www.agios.com

Country

USA

Full Time Employees

486

Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatric patients; and for the treatment of adult patients with non-transfusion dependent and transfusion-dependent alpha- or beta-thalassemia. In addition, it develops tebapivat, a PK activator for the treatment of lower-risk myelodysplastic syndrome and hemolytic anemias; AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria (PKU); and AG-236, an siRNA in-licensed from Alnylam, targeting the transmembrane serine protease 6 (TMPRSS6) gene for the treatment of polycythemia vera. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

“Agios Pharm Earnings” Can Refer to the Agios Pharm Earnings Date

Some people say “Agios Pharm earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Agios Pharm position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Agios Pharm Stock on the Earnings Date

If you own Agios Pharm stock (AGIO) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Agios Pharm might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Agios Pharm shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Agios Pharm Earnings

You can contact us any time if you would like to ask questions about Agios Pharm earnings or anything else related to the stock market.